Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
about
A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on DialysisAn open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.Effects of Peginesatide Injection on QTc Interval in Healthy Adults.Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal DialysisProfile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis.Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments.Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.Peginesatide for the treatment of renal disease-induced anemia.Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promiseAnaemia: The safety and efficacy of peginesatide in patients with CKD.
P2860
Q28533979-4E341F0B-3DF6-45E8-9A33-B372931828E2Q34398392-8EAA088B-5045-4E7B-84E6-AA0D7CE9032DQ35810325-7C12F549-8436-42D9-B138-FDA10A57B77FQ35904444-60D7D54C-E68D-4BFA-8719-7166C9CACF4FQ36039649-47D51C42-45E2-493B-B437-2B983FE0C3E0Q36058555-08E2439C-DD58-4F80-B408-83EFE7ED9762Q37157237-99876A72-7DF0-4708-85A5-764F8B03F9CEQ37999380-1B488B1B-DE86-4BDC-921F-AA1F7B0A720BQ38029405-78C44581-8919-4EC1-ACFB-801CAFC7E4BCQ38075798-5900F1C8-4674-4287-82B3-6B1239466EC0Q38090725-DFADE585-7E23-480D-BA9F-B2DBBAFE85B4Q38134288-07EC88A2-B5A2-45E8-B377-E307E2CEB63BQ38934661-AF6F7C51-6053-426C-9F4D-91D3BF97AFAEQ44067854-C2526EF6-28FD-4922-93E9-3C5D78AA301F
P2860
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Dose-finding study of peginesa ...... ronic kidney disease patients.
@ast
Dose-finding study of peginesa ...... ronic kidney disease patients.
@en
type
label
Dose-finding study of peginesa ...... ronic kidney disease patients.
@ast
Dose-finding study of peginesa ...... ronic kidney disease patients.
@en
prefLabel
Dose-finding study of peginesa ...... ronic kidney disease patients.
@ast
Dose-finding study of peginesa ...... ronic kidney disease patients.
@en
P2093
P2860
P356
P1476
Dose-finding study of peginesa ...... ronic kidney disease patients.
@en
P2093
Andrzej Wiecek
Anne-Marie Duliege
Ashraf Mikhail
Beatriz Tucker
Carol Francisco
Iain C Macdougall
Iain MacPhee
Krishna R Polu
Magdi Yaqoob
Martha Mayo
P2860
P304
P356
10.2215/CJN.10831210
P577
2011-09-22T00:00:00Z